We are live on ! Find out more

1,602 hedge funds and large institutions have $125B invested in Merck in 2014 Q1 according to their latest regulatory filings, with 115 funds opening new positions, 595 increasing their positions, 704 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 115 | Existing positions closed: 64

38% more call options, than puts

Call options by funds: $1.01B | Put options by funds: $731M

30% more funds holding in top 10

Funds holding in top 10: 113147 (+34)

14% more capital invested

Capital invested by funds: $109B → $125B (+$15.6B)

2% more funds holding

Funds holding: 1,5671,602 (+35)

0.05% less ownership

Funds ownership: 78.02%77.96% (-0.05%)

15% less repeat investments, than reductions

Existing positions increased: 595 | Existing positions reduced: 704

Holders
1,602
Holders Change
+35
Holders Change %
+2.23%
% of All Funds
46.25%
Holding in Top 10
147
Holding in Top 10 Change
+34
Holding in Top 10 Change %
+30.09%
% of All Funds
4.24%
New
115
Increased
595
Reduced
704
Closed
64
Calls
$1.01B
Puts
$731M
Net Calls
+$277M
Net Calls Change
-$157M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital World Investors
1
Capital World Investors
California
$9.85B +$247M +4,768,064 +3%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$8.92B +$166M +3,213,700 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$8.4B +$248M +4,795,589 +3%
State Street
4
State Street
Massachusetts
$7.29B -$201M -3,885,694 -3%
BIT
5
BlackRock Institutional Trust
California
$4.51B +$127M +2,454,752 +3%
Franklin Resources
6
Franklin Resources
California
$4.2B -$418M -8,067,138 -9%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$3.38B +$340M +6,567,190 +12%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$3.25B +$225M +4,335,558 +8%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$2.56B +$112M +2,160,835 +5%
Northern Trust
10
Northern Trust
Illinois
$2.48B -$18.7M -360,714 -0.8%
JP Morgan Chase
11
JP Morgan Chase
New York
$2.34B +$425M +8,209,999 +24%
Dodge & Cox
12
Dodge & Cox
California
$2.27B -$480M -9,263,587 -18%
BFA
13
BlackRock Fund Advisors
California
$2.2B +$56.7M +1,095,046 +3%
Deutsche Bank
14
Deutsche Bank
Germany
$1.68B +$229M +4,412,993 +17%
Invesco
15
Invesco
Georgia
$1.47B -$161M -3,116,933 -10%
BG
16
BlackRock Group
United Kingdom
$1.47B +$45.8M +884,694 +3%
Jennison Associates
17
Jennison Associates
New York
$1.32B +$608M +11,732,725 +92%
Barrow, Hanley, Mewhinney & Strauss
18
Barrow, Hanley, Mewhinney & Strauss
Texas
$1.29B -$363M -7,005,651 -23%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.28B +$23.1M +445,790 +2%
Norges Bank
20
Norges Bank
Norway
$1.26B -$4.7M -90,692 -0.4%
Goldman Sachs
21
Goldman Sachs
New York
$1.17B -$141M -2,728,409 -11%
BA
22
BlackRock Advisors
Delaware
$1.14B +$30.1M +580,626 +3%
Ameriprise
23
Ameriprise
Minnesota
$1.09B +$88.8M +1,714,003 +9%
Bank of America
24
Bank of America
North Carolina
$1.02B -$8.75M -168,993 -0.9%
TCIM
25
TIAA CREF Investment Management
New York
$892M -$15M -289,506 -2%

MRK Hedge Fund Activity: Q1 2014 in Review

1,602 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2014, worth a combined $125B — up 14% from $109B a quarter earlier.

Buyers outnumbered sellers: 115 funds opened new MRK positions and 64 closed out — a net gain of 51 holders — while 595 added to existing stakes and 704 trimmed.

The largest buyer was Jennison Associates, adding an estimated $608M. The largest seller was Dodge & Cox, cutting an estimated $480M.

  • 1,602 institutional investors held Merck (MRK) as of Q1 2014, up from 1,567 in Q4 2013.
  • Funds reported $125B of Merck stock for Q1 2014, up 14% quarter-over-quarter.
  • 115 funds opened new Merck positions in Q1 2014 and 64 closed out, a net change of +51 holders.
  • The largest Merck buyer in Q1 2014 was Jennison Associates, an estimated $608M added.
  • The largest Merck seller in Q1 2014 was Dodge & Cox, an estimated $480M sold.

Based on aggregated 13F filings for Q1 2014.